(ANSA-AFP) - COPENHAGEN, 19 MAR - Denmark has announced that it will wait before a possible resumption of anti-Covid vaccination with AstraZeneca serum, declared "safe and effective" by the European regulator.
"Our decision to suspend vaccination with AstraZeneca's Covid-19 vaccine until week 12 (March 22-28) remains in force," said the director of the Danish health agency Sundhedsstyrelsen, Soren Brostrom, in a statement released late yesterday evening.
"In the coming days, Sundhedsstyrelsen and the Danish Medicines Agency will assess the impact of the EMA (European Medicines Agency) opinion on AstraZeneca's Covid-19 vaccine for the Danish vaccination program," he added.
Last week, Denmark was the first country to completely suspend vaccination with AstraZeneca, before being followed by fifteen, mostly European, countries.
According to the Danish authorities, although confirming the benefits of the vaccine, the European regulator "does not rule out a link between the few known cases of rare but serious blood clots and vaccination with AstraZeneca vaccine".
Denmark is currently investigating ten cases, including one fatal, in which blood clots or symptoms of blood clots have occurred after vaccination, in over 140,000 people who have received one dose of the Swedish-British vaccine.
All Nordic countries except Finland had suspended the use of the vaccine due to fears of blood clots.
Sweden and Norway have already announced that they will wait before a possible recovery.
(ANSA-AFP).